Le Lézard
Classified in: Science and technology, Business
Subjects: STS, SHM

Share split in Embracer Group


STOCKHOLM, Sept. 23, 2021 /PRNewswire/ -- On 16 September 2021, the annual general meeting in Embracer Group AB resolved on a share split 2:1 whereby an existing A share and an existing B share each will be split into two new shares respectively. The board of directors was also authorized by the annual general meeting to determine the record date for the split.

The board of directors has determined that the record date for the split of the shares in the company will be 30 September 2021. The last day of trading in the company's shares before the share split is 28 September 2021. The first day of trading in the company's shares after the share split is 29 September 2021.

The share split will be carried out automatically through Euroclear Sweden AB and shareholders do not need to take any action.

New ISIN codes for the A share is: SE0016828503 and the B share: SE0016828511.

The number of shares after completion of the share split will be 1,014,949,830, divided on 66,798,274 A shares and 948,151,556 B shares (before the share split 507,474,915 shares in total). The quota value of each share will be changed from approximately SEK 0.0027 to approximately SEK 0.0013.

For additional information, please contact:

Lars Wingefors, Co-founder and Group CEO of Embracer Group AB
Tel: +46 708 47 19 78
E-mail: [email protected]

About Embracer Group

Embracer Group is the parent company of businesses developing and publishing PC, console, and mobile games for the global games market. The Group has an extensive catalogue of over 240 owned franchises, such as Saints Row, Goat Simulator, Dead Island, Darksiders, Metro, MX vs ATV, Kingdoms of Amalur, TimeSplitters, Satisfactory, Wreckfest, Insurgency, World War Z, and Borderlands, amongst many others.

With its head office based in Karlstad, Sweden, Embracer Group has a global presence through its eight operative groups: THQ Nordic, Koch Media, Coffee Stain, Amplifier Game Invest, Saber Interactive, DECA Games, Gearbox Entertainment, and Easybrain. The Group has 80 internal game development studios and is engaging more than 8,500 employees and contracted employees in more than 40 countries.

Embracer Group's shares are publicly listed on Nasdaq First North Growth Market Stockholm under the ticker EMBRAC B with FNCA Sweden AB as its Certified Adviser: [email protected]; +46-8-528 00 399.

Subscribe to press releases and financial information: https://embracer.com/investors/subscription/

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/embracer-group-ab/r/share-split-in-embracer-group,c3419915

The following files are available for download:

https://mb.cision.com/Main/15049/3419915/1471875.pdf

Press release - Share split in Embracer Group


These press releases may also interest you

at 17:35
Perficient, Inc. ("Perficient" or "the Company"), a leading global digital consultancy transforming the world's largest enterprises and biggest brands, today announced that it has entered into a definitive agreement to be acquired by an affiliate of...

at 17:35
Perficient, Inc. ("Perficient"), the leading global digital consultancy transforming the world's largest enterprises and biggest brands, today reported its financial results for the quarter ended March 31, 2024. Financial Highlights For the...

at 15:32
A report from GDToday:  On the evening of May 3, 2024, the Guangzhou Opera House dazzled audiences with the performance of "Marco Polo," a captivating opera commissioned by the esteemed venue. In order to commemorate the 700th anniversary of the...

at 13:20
Garrett Smith, Founder and CEO of Community Capital Technology Inc. ("Community Capital"), will be attending the Milken Institute Global Conference ("MI Global") May 5-8, 2024 in Los Angeles. The event brings together global executives and...

at 13:16
Quarterhill Inc. ("Quarterhill" or the "Company") , a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS")...

at 12:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...



News published on and distributed by: